SL-75102

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 13:24, 11 November 2014. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

SL-75102
Names
IUPAC name
4-[[(4-Chlorophenyl)-(3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]butanoic acid
Other names
Progabide acid; LS-187121; SL-75-102-00
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
  • InChI=1S/C17H15ClFNO3/c18-12-5-3-11(4-6-12)17(20-9-1-2-16(22)23)14-10-13(19)7-8-15(14)21/h3-8,10,20H,1-2,9H2,(H,22,23)/b17-14-
    Key: AJPSGLKFKRSEBJ-VKAVYKQESA-N
  • C1=CC(=CC=C1C(=C2C=C(C=CC2=O)F)NCCCC(=O)O)Cl
Properties
C17H15ClFNO3
Molar mass 335.76 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

SL 75102 is a metabolite of progabide and an anticonvulsant GABA agonist.[1][2]

References

  1. ^ "Progabide and SL 75102 binding to plasma proteins and red blood cells in humans". Int J Clin Pharmacol Ther Toxicol. 25 (4): 178–84. April 1987. PMID 3583466.
  2. ^ "Anticonvulsant effect of SL 75 102 in adult and immature rats". Physiol Res. 46 (1): 73–6. 1997. PMID 9728525.